Shares of Edwards Lifesciences are up nearly 3% to $70.54 in afternoon trading. The Betaville blog, which is edited by Ben Harrington and focused on M&A, has mentioned a rumor related to Edwards, contacts tell The Fly.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EW:
- Edwards Lifesciences price target lowered to $71 from $82 at Truist
- Edwards Lifesciences call volume above normal and directionally bullish
- Edwards Lifesciences price target lowered to $80 from $90 at Barclays
- Edwards Lifesciences price target lowered to $80 from $90 at Wells Fargo
- Edwards Lifesciences says EPS lower in 2025 than in 2024